Newsletter Subscribe
Enter your email address below and subscribe to our newsletter
FDA approves new drug Rasonque to treat advanced pancreatic cancer
Share your love
The US FDA on Wednesday approved Revolution Medicines’ Rasonque for advanced pancreatic cancer, opening a new treatment option for patients with metastatic disease. A large trial found the once-daily pill doubled survival rates, offering fresh hope for people who have exhausted other treatments.
